Pharmaceutical firms are racing to be the primary to bring an oral version of semaglutide to the market and it could come inside the next 12 months
A pill type of Ozempic is on its way as drugmakers reportedly race to turn out to be the primary comapny to bring an oral version of the diabetes drug (which can be used off-label for weight-loss) to the market. Until now, semaglutide – sold under branded names including Ozempic, Wegovy and Mounjaro – has been predominantly available as an injection, but data from several new studies suggests that a latest pill might be just as effective in reducing weight and blood sugar for people each with...
Continue reading
0 Comments